MPLT vs PGR · $1.24B cap vs P/E 10, rev $45.80B
MapLight Therapeutics, Inc. Common Stock (MPLT) versus Progressive Corp (PGR) — a side-by-side from cached financials, not a winner call.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Progressive Corp (PGR) is a insurance - property & casualty company listed on NYSE.
MPLT does not have a complete income-statement cache yet.
Latest reported PGR revenue for 2026-06-30 was $45.80B. Net income was $6.13B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
MPLT currently screens at market cap $1.24B. PGR currently screens at market cap $119.28B and trailing P/E 10.4.
Not investment advice. Open the MPLT and PGR stock pages for the full models.
Not investment advice.